100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NUR 211 Immune Disorders Summary $13.99   Add to cart

Summary

NUR 211 Immune Disorders Summary

 12 views  0 purchase

This is a comprehensive and detailed summary on Chapter 36 Immune Disorders.

Preview 2 out of 11  pages

  • No
  • Chapter 36
  • October 19, 2024
  • 11
  • 2021/2022
  • Summary
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
All documents for this subject (6)
avatar-seller
anyiamgeorge19
Chapter 36 Management of Patients with Immune Deficiency Disorder

Vocabulary:
 Candidiasis: fungal infection of the skin and mucus membranes that causes Candida species
 Enzyme immunoassay (EIA): blood test that can determine presence of antibodies to HIV in blood or saliva, a variant of
this test is called enzyme-linked immunosorbent assay (ELISA)
 HIV-1: retrovirus isolated and recognized as the etiologic agent of HIV disease
 HIV encephalopathy: clinical syndrome characterized by a progressive decline in cognitive, behavioral, and motor function
 Immune reconstitution inflammatory syndrome (IRIS): syndrome that results from rapid restoration of pathogen-
specific immune response to opportunistic infections
 Kaposi sarcoma: malignancy that involved the epithelial layer of blood and lymphatic vessels
 Latent reservoir: the integrated HIV provirus within the CD4+ T cell during the resting memory state, does not express viral
proteins and is invisible to the immune system and antiviral medications
 Mycobacterium avium complex (MAC): infection caused by mycobacterial organisms that commonly causes respiratory
illness but can also infect other body systems
 Opportunistic infection: illness caused by various organisms some of which usually do not cause diseases in normal
immune system patients
 Peripheral neuropathy: disorder characterized by sensory loss, pain, muscle weakness and wasting of muscles in the hands
or legs and feet
 Pneumocystis pneumonia (PCP): common opportunistic lung infection; pathogen implication is most commonly fungus
 Polymerase chain reaction: sensitive lab technique that can detect and quantify HIV in person’s blood or lymph nodes
 Post-exposure prophylaxis (PEP): taking antiretroviral medications ASAP, but not more than 72 hours after possible
exposure to HIV; 2-3 drugs are usually prescribed which must be taken for 28 days
 Pre-exposure prophylaxis (PrEP): prevention method for HIV-negative people who are @ risk for contraction, taking
specific combination of HIV medicines daily; use with condoms and other preventive tools
 Progressive multifocal leukoencephalopathy: opportunistic infection that infects brain tissue and causes damage to the
brain and spinal cord
 Retrovirus: virus that carries genetic material in RNA instead on DNA and contains reverse transcriptase
 Reverse transcriptase: enzyme that transforms single-stranded RNA into double stranded DNA
 Viral load test: measures the quantity of HIV RNA or DNA in the blood
 Viral set point: amount of virus present in the blood after the initial burst of viremia and the immune response that follows
 Wasting syndrome: involuntary weight loss consisting of both lean and fat body mass

Reading Notes:
Introduction
 Immune system protects against foreign substances, proliferation of neoplastic cells, and key role in inflammation and
healing

Primary Immune Deficiencies

 Majority of PIDDs are diagnosed in infancy with male to female ratio of 5 to 1
 Early adulthood diagnosis are frequently confounded by frequent use of antibiotics that mask symptoms

Pathophysiology
 More than 270 different genes are associated with PIDDs
 Prevent the body from developing normal immune responses resulting in numerous disorders with differing clinical
symptoms

Clinical Manifestations
 Multiple infections despite aggressive treatment, infections with unusual or opportunistic organisms, failure to thrive and
poor growth, positive family history
 Look at chart 36-1 on pg. 1023



Assessment and Diagnostic Findings
 Onset in delay between onset of symptoms and time of Dx of PIDDs

, Chapter 36 Management of Patients with Immune Deficiency Disorder

 Family Hx should be carefully checked because of genetic origins of PIDDs
 Lab tests are used to identify antibody deficiencies, cellular T cell defects, neutrophil disorders and complement deficiencies
 CBC with diff should be analyzed first
 Lymphopenia may indicate an immunologic abnormality; serum Ig levels and antibody responses to vaccines should be
assessed to detect a humoral immune defect
o Use age-matched normal ranges -> levels change as person ages

Prevention
 Live vaccines are contradicted in patients with antibody deficiency disorders -> unable to generate antibodies and live
substance in vaccine can cause death
 Prenatal testing should be done

Medical Management
 Indication for PIDD include unusually frequent and severe infections -> referral to immunologist
 Neutroepnic patients are at increased risk for development of severe infections
 Infection control -> emergence of multi-drug-resistant organisms
 HSCT is curative -> stem cells may be from embryo or adults -> toxicity and reduced efficacy are limitations
 Another therapy uses cells as vehicles for delivery of genes or gene products -> gene therapy -> many AE such as toxicity

Pharmacologic Therapy
 Depends on type and severity of presenting infections in the PIDD Dx
 PPx drug treatment can prevent some bacterial and fungal infections -> emergence of resistant organisms
 Patients with antibody deficiencies receive regular Ig replacement therapy including immunoglobulin IV (IVIG) and subQ
immunoglobulin (SCIG) to provide functional antibodies

Nursing Management
 Many patients have comorbid autoimmune disorders such as thyroid disease, RA, and IBD
 Many require immunosuppressant therapy to ensure engraftment is successful -> nursing care must be meticulous
 Hand hygiene and infection prevention look at chart 71-2 for methods of prevention
 Identify S/S of infection early
 Education for how to administer therapy @ home chart 36-1 pg. 1023

Acquired Immune Deficiency

 Can be acquired from chemotherapy treatment or from infection such as with HIV
 Prevention, early detection, and ongoing treatment are important aspects of care for patient living with HIV/AIDS
o PLWHA

HIV Infection and AIDS
 1st decade since detection focused on recognition and treatment of opportunistic disease and introduction of PPx against
opportunistic infections
 2nd decade had progress in development of highly active antiretroviral drug therapy (HAART)
 3rd decade focused on issues of preventing new infections, adherence to antiretroviral therapy (ART), development of 2 nd
generation combination medications that affect different stages of viral lifestyle, and continued need for effective vaccine
 HIV antibody test: enzyme immunoassay (EIA) or variant ELISA -> 1984 allowing for early Dx before onset of symptoms
 HIV is managed more as a chronic disease in outpatient setting while AIDS may involve acute conditions that require
hospitalization


Epidemiology
 Lab evidence is preferred overall clinical S/S
 HIV can be classified between 0-unknown stages
o 0 indicates early infection inferred from lab tests
o Stages 1, 2, 3 are based on CD4+ T-lymphocyte count
o Cases with no info on CD4+ T-lymphocyte are classified as unknown

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller anyiamgeorge19. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72042 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.99
  • (0)
  Add to cart